Abstract
Multimodal mass spectrometry imaging (MSI) is a leading approach for investigating the molecular processes within biological samples. The parallel detection of compounds including metabolites, lipids, proteins, and metal isotopes allows for a more holistic understanding of tissue microenvironments. Universal sample preparation is a primary enabler for samples of the same set to be run across multiple modalities. Using the same method and materials for a cohort of samples reduces any potential variability during sample preparation and allows for comparable analysis across analytical imaging techniques. Here, the MSI workflow is describing a sample preparation protocol for the analysis of three-dimensional (3D) cell culture models. The analysis of biologically relevant cultures by multimodal MSI offers a method in which models of cancer and disease can be studied for the use in early-stage drug development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Li H, Hummon AB (2011) Imaging mass spectrometry of three-dimensional cell culture systems. Anal Chem 83(22):8794–8801
Tucker LH et al (2019) Untargeted metabolite mapping in 3D cell culture models using high spectral resolution FT-ICR mass spectrometry imaging. Anal Chem 91(15):9522–9529
Robison HM et al (2020) Identification of lipid biomarkers of metastatic potential and gene expression (HER2/p53) in human breast cancer cell cultures using ambient mass spectrometry. Anal Bioanal Chem 412(12):2949–2961
Zang Q et al (2021) Spatially resolved metabolomics combined with multicellular tumor spheroids to discover cancer tissue relevant metabolic signatures. Anal Chim Acta 1155:338342
Flint LE et al (2021) Comparison of osteosarcoma aggregated tumour models with human tissue by multimodal mass spectrometry imaging. Meta 11(8)
Bergmann S et al (2018) Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics. Nat Protoc 13(12):2827–2843
LaBonia GJ et al (2018) iTRAQ quantitative proteomic profiling and MALDI-MSI of colon cancer spheroids treated with combination chemotherapies in a 3D printed fluidic device. Anal Chem 90(2):1423–1430
Liu X et al (2018) MALDI mass spectrometry imaging for evaluation of therapeutics in colorectal tumor organoids. J Am Soc Mass Spectrom 29(3):516–526
Liu X, Weaver EM, Hummon AB (2013) Evaluation of therapeutics in three-dimensional cell culture systems by MALDI imaging mass spectrometry. Anal Chem 85(13):6295–6302
PalubeckaitÄ— I et al (2020) Mass spectrometry imaging of endogenous metabolites in response to doxorubicin in a novel 3D osteosarcoma cell culture model. J Mass Spectrom 55(4):e4461
Theiner S et al (2017) Fast high-resolution laser ablation-inductively coupled plasma mass spectrometry imaging of the distribution of platinum-based anticancer compounds in multicellular tumor spheroids. Anal Chem 89(23):12641–12645
Takáts Z et al (2004) Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 306(5695):471–473
Banerjee S et al (2017) Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids. Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids 114(13):3334–3339
Guenther S et al (2015) Spatially resolved metabolic phenotyping of breast cancer by desorption electrospray ionization mass spectrometry. Cancer Res 75(9):1828–1837
Santoro AL et al (2020) In situ DESI-MSI Lipidomic profiles of breast cancer molecular subtypes and precursor lesions. Cancer Res 80(6):1246–1257
Lear J et al (2012) High-Resolution Elemental Bioimaging of Ca, Mn, Fe, Co, Cu, and Zn Employing LA-ICP-MS and Hydrogen Reaction Gas. Anal Chem 84(15):6707–6714
Voloaca OM et al (2020) Laser ablation inductively coupled plasma mass spectrometry as a novel clinical imaging tool to detect asbestos fibres in malignant mesothelioma. Laser ablation inductively coupled plasma mass spectrometry as a novel clinical imaging tool to detect asbestos fibres in malignant mesothelioma 34(21):e8906
Chang Q et al (2017) Imaging Mass. Cytometry 91(2):160–169
Kuett L et al (2022) Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment. Nature Cancer 3(1):122–133
Buchberger AR et al (2018) Mass spectrometry imaging: a review of emerging advancements and future insights. Anal Chem 90(1):240–265
Goodwin RJ, Pitt AR (2010) Mass spectrometry imaging of pharmacological compounds in tissue sections. Bioanalysis 2(2):279–293
Wang Y, Hummon AB (2021) MS imaging of multicellular tumor spheroids and organoids as an emerging tool for personalized medicine and drug discovery. J Biol Chem 297(4):101139
Breslin S, O’Driscoll L (2016) The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance. Oncotarget 7(29):45745–45756
Cukierman E et al (2001) Taking cell-matrix adhesions to the third dimension. Science 294(5547):1708–1712
Bassi G et al (2020) Scaffold-based 3D cellular models mimicking the heterogeneity of osteosarcoma stem cell niche. Sci Rep 10(1):22294
Doyle AD et al (2015) Local 3D matrix microenvironment regulates cell migration through spatiotemporal dynamics of contractility-dependent adhesions. Nat Commun 6(1):8720
Johnson J et al (2020) Sample preparation strategies for high-throughput mass spectrometry imaging of primary tumor organoids. Sample preparation strategies for high-throughput mass spectrometry imaging of primary tumor organoids 55(4):e4452
Schwartz SA, Reyzer ML, Caprioli RM (2003) Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. J Mass Spectrom 38(7):699–708
Dannhorn A et al (2020) Universal sample preparation unlocking multimodal molecular tissue imaging. Anal Chem 92(16):11080–11088
Gill EL et al (2017) Precast gelatin-based molds for tissue embedding compatible with mass spectrometry imaging. Anal Chem 89(1):576–580
Swales JG et al (2018) Quantitation of endogenous metabolites in mouse tumors using mass-spectrometry imaging. Anal Chem 90(10):6051–6058
Flint LE et al (2020) Characterization of an aggregated three-dimensional cell culture model by multimodal mass spectrometry imaging. Anal Chem 92(18):12538–12547
Palubeckaite, I.C., L.; Smith, D.P.; Cole, L.M.; Bram, H.; Le Maitre, C.; Clench, M. R.; Cross, N.A; , Mass spectrometry imaging of endogenous metabolites in response to doxorubicin in a novel 3D osteosarcoma cell culture model. J Mass Spectrom, 2019. 55(4): p. e4461
McQuin C et al (2018) CellProfiler 3.0: Next-generation image processing for biology. PLoS Biol 16(7):e2005970
Berg S et al (2019) Ilastik: interactive machine learning for (bio)image analysis. Nat Methods 16(12):1226–1232
Seaman C (2017) Laser ablation inductively coupled plasma mass spectrometry imaging of plant metabolites. Methods Mol Biol 1618:125–135
Weiskirchen R et al (2019) Software solutions for evaluation and visualization of laser ablation inductively coupled plasma mass spectrometry imaging (LA-ICP-MSI) data: a short overview. J Chem 11(1):16
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Flint, L. (2023). Multimodal Mass Spectrometry Imaging of an Aggregated 3D Cell Culture Model. In: Cole, L.M., Clench, M.R. (eds) Imaging Mass Spectrometry. Methods in Molecular Biology, vol 2688. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3319-9_13
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3319-9_13
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3318-2
Online ISBN: 978-1-0716-3319-9
eBook Packages: Springer Protocols